» Authors » Raju R Raval

Raju R Raval

Explore the profile of Raju R Raval including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 40
Citations 1696
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Upadhyay R, Elguindy A, Salts L, Donovan K, Sengupta S, Wang K, et al.
Int J Radiat Oncol Biol Phys . 2025 Feb; PMID: 39993542
Purpose: Radiation necrosis (RN) is a dose-limiting toxicity of stereotactic radiosurgery (SRS) for brain metastases. Oral corticosteroids are not optimal for long-term management, given multiple side effects. Boswellia serrata (BS)...
2.
Singh R, Roubil J, Lehrer E, Muanamputu G, Thomas E, Beyer S, et al.
Pract Radiat Oncol . 2025 Feb; PMID: 39954813
Purpose: The implications of margin expansions on local control (LC) and radionecrosis (RN) for treating brain metastases (BMs) with stereotactic radiosurgery (SRS) remain unclear. We performed a systematic review and...
3.
Hadley C, Matsui J, Blakaj D, Beyer S, Grecula J, Chakravarti A, et al.
Cancers (Basel) . 2024 Nov; 16(22). PMID: 39594689
Melanoma remains a formidable challenge in oncology, causing the majority of skin cancer deaths in the United States, with brain metastases contributing substantially to this mortality. This paper reviews the...
4.
Mansur G, Alsavaf M, Pasquini L, Abouammo M, Biswas C, Kumar P, et al.
Pituitary . 2024 Aug; 27(5):455-467. PMID: 39141205
Purpose: This study investigates the rare occurrence of tumor-to-tumor metastasis in Pituitary Neuroendocrine Tumors (PitNETs), also known as pituitary adenomas, aiming to enhance understanding of its diagnostic and therapeutic challenges....
5.
Upadhyay R, Klamer B, Matsui J, Chakravarthy V, Scharschmidt T, Yeager N, et al.
Cancers (Basel) . 2024 Jun; 16(11). PMID: 38893209
Background: Pediatric patients with metastatic and/or recurrent solid tumors have poor survival outcomes despite standard-of-care systemic therapy. Stereotactic ablative radiation therapy (SABR) may improve tumor control. We report the outcomes...
6.
Sloan A, Winter K, Gilbert M, Aldape K, Choi S, Wen P, et al.
Neuro Oncol . 2024 Jun; 26(9):1628-1637. PMID: 38874333
Background: Immune checkpoint inhibitors (ICIs) have efficacy in several solid tumors but limited efficacy in glioblastoma (GBM). This study evaluated the safety of anti-CTLA-4 and anti-PD-1 ICIs alone or in...
7.
Upadhyay R, Palmer J, Klamer B, Perlow H, Schoenhals J, Ghose J, et al.
Adv Radiat Oncol . 2024 May; 9(7):101509. PMID: 38799108
Background: Current standard of care treatment for patients with ≥15 brain metastases (BM) is whole brain radiation therapy (WBRT), despite poor neurocognitive outcomes. We analyzed our institutional experience of treating...
8.
Perlow H, Nalin A, Ritter A, Addington M, Ward A, Liu M, et al.
Adv Radiat Oncol . 2024 Feb; 9(2):101337. PMID: 38405310
Purpose: Recent advances to preserve neurocognitive function in patients treated for brain metastases include stereotactic radiosurgery, hippocampal avoidance whole brain radiation therapy (WBRT), and memantine administration. The hippocampus, corpus callosum,...
9.
Perlow H, Matsui J, Ewing A, Cadieux C, Dibs K, Upadhyay R, et al.
Adv Radiat Oncol . 2024 Feb; 9(3):101424. PMID: 38379893
Introduction: Craniospinal irradiation (CSI) is indicated for adult patients diagnosed with leptomeningeal disease (LMD). Proton-based vertebral body sparing (VBS) CSI has been explored with pediatric patients to minimize hematologic toxicity;...
10.
Upadhyay R, Klamer B, Perlow H, White J, Bazan J, Jhawar S, et al.
Cancers (Basel) . 2024 Jan; 16(1). PMID: 38201564
Background: Breast cancer is the second most common cause of brain metastases (BM). Despite increasing incidence of BM in older women, there are limited data on the optimal management of...